Tu1365 Low Dose Naltrexone in the Treatment of Crohn's Disease: A Case Series

Gastroenterology
April 2015
http://www.gastrojournal.org/article/S0016-5085(15)32952-8/abstract

Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial

Dig Dis Sci
July 2011
https://pubmed.ncbi.nlm.nih.gov/21380937/ 

Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient

Inflamm Bowel Dis
September 2010
https://academic.oup.com/ibdjournal/article/16/9/1457/4628412

Low-dose naltrexone therapy improves active Crohn's disease

Am J Gastroenterol
April 2007
https://pubmed.ncbi.nlm.nih.gov/17222320/

Objectives: Endogenous opioids and opioid antagonists have been shown to play a role in healing and repair of tissues. In an open-labeled pilot prospective trial, the safety and efficacy of low-dose naltrexone (LDN), an opioid antagonist, were tested in patients with active Crohn's disease.

Psychoneuroimmunological approach to gastrointestinal related pain

Scand J Pain
October 2017
https://pubmed.ncbi.nlm.nih.gov/29122501/

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

J Transl Med
09 March 2018
https://pubmed.ncbi.nlm.nih.gov/29523156/

Low dose naltrexone for induction of remission in Crohn's disease

Cochrane Database Syst Rev
01 April 2018
https://pubmed.ncbi.nlm.nih.gov/29607497/

Low-Dose Naltrexone in Diseases' Treatment: Global Review

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders

Int J Pharm Compd
Mar-Apr 2010
https://mail.google.com/mail/u/0?ui=2&ik=b5d7923c33&attid=0.2&permmsgid=msg-f:1668161843235939361&th=1726805badf06421&view=att&disp=safe

The Benefits of Low Dose Naltrexone

JewishLink
21 May 2020
https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone